
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17058969
[patent_doc_number] => 11103551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Method for treatment or prevention of a cancer
[patent_app_type] => utility
[patent_app_number] => 15/807898
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 59
[patent_no_of_words] => 11479
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807898 | Method for treatment or prevention of a cancer | Nov 8, 2017 | Issued |
Array
(
[id] => 12580854
[patent_doc_number] => 20180085447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Methods To Analyze Genetic Alterations In Cancer To Identify Therapeutic Peptide Vaccines And Kits Therefore
[patent_app_type] => utility
[patent_app_number] => 15/791301
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/791301 | Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore | Oct 22, 2017 | Issued |
Array
(
[id] => 12637071
[patent_doc_number] => 20180104187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => EXTRACELLULAR VESICLE-BASED DIAGNOSTICS AND ENGINEERED EXOSOMES FOR TARGETED THERAPEUTICS AGAINST CANCER
[patent_app_type] => utility
[patent_app_number] => 15/788709
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15788709
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/788709 | Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer | Oct 18, 2017 | Issued |
Array
(
[id] => 14838903
[patent_doc_number] => 20190277852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Method for Determining Prognosis of Cancer
[patent_app_type] => utility
[patent_app_number] => 16/343458
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343458 | Method for Determining Prognosis of Cancer | Oct 18, 2017 | Abandoned |
Array
(
[id] => 12642165
[patent_doc_number] => 20180105886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => DETECTING NEOPLASM
[patent_app_type] => utility
[patent_app_number] => 15/724890
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15724890
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/724890 | Detecting neoplasm | Oct 3, 2017 | Issued |
Array
(
[id] => 14534615
[patent_doc_number] => 20190202929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF AML USING USP10 BIOMARKERS AND MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/331712
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331712 | Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators | Sep 19, 2017 | Issued |
Array
(
[id] => 13265391
[patent_doc_number] => 10144771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Lung cancer diagnosis marker, antibody and application thereof
[patent_app_type] => utility
[patent_app_number] => 15/710794
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 4177
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/710794 | Lung cancer diagnosis marker, antibody and application thereof | Sep 19, 2017 | Issued |
Array
(
[id] => 12160296
[patent_doc_number] => 20180031563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/706105
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 45712
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15706105
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/706105 | USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | Sep 14, 2017 | Abandoned |
Array
(
[id] => 14578251
[patent_doc_number] => 20190216734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => A Novel Method For Producing Low Viscous And Highly Concentrated Biopharmaceutical Drug Products In Liquid Formulation
[patent_app_type] => utility
[patent_app_number] => 16/332716
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 239
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332716
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332716 | Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation | Sep 14, 2017 | Issued |
Array
(
[id] => 16476493
[patent_doc_number] => 10851422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Methods of determining an immune response score
[patent_app_type] => utility
[patent_app_number] => 15/705571
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6499
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705571 | Methods of determining an immune response score | Sep 14, 2017 | Issued |
Array
(
[id] => 15963101
[patent_doc_number] => 20200165302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => MODIFIED VSV-G AND VACCINES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/332909
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332909 | MODIFIED VSV-G AND VACCINES THEREOF | Sep 13, 2017 | Abandoned |
Array
(
[id] => 17126580
[patent_doc_number] => 20210301349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING A TUMOR SUPPRESSOR DEFICIENT CANCER
[patent_app_type] => utility
[patent_app_number] => 16/328623
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328623 | COMPOSITIONS AND METHODS FOR TREATING A TUMOR SUPPRESSOR DEFICIENT CANCER | Aug 28, 2017 | Abandoned |
Array
(
[id] => 17287097
[patent_doc_number] => 11203637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Anti-Tim-3 antibodies and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/328047
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 17953
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 292
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328047 | Anti-Tim-3 antibodies and use thereof | Aug 24, 2017 | Issued |
Array
(
[id] => 12241214
[patent_doc_number] => 20180074076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'RATIO BASED BIOMARKERS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/676194
[patent_app_country] => US
[patent_app_date] => 2017-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 37603
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15676194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/676194 | RATIO BASED BIOMARKERS AND METHODS OF USE THEREOF | Aug 13, 2017 | Abandoned |
Array
(
[id] => 17307385
[patent_doc_number] => 11208478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Methods of detecting and treating a tumor expressing pT346 PDK1
[patent_app_type] => utility
[patent_app_number] => 16/323648
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19485
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323648
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323648 | Methods of detecting and treating a tumor expressing pT346 PDK1 | Aug 3, 2017 | Issued |
Array
(
[id] => 12975766
[patent_doc_number] => 20170340672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/669707
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15669707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/669707 | Chimeric antigen receptor and methods of use thereof | Aug 3, 2017 | Issued |
Array
(
[id] => 12185485
[patent_doc_number] => 20180044422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'TREATING SOLID TUMOR BY TARGETING DECTIN-1 SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 15/664720
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 28346
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15664720
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/664720 | TREATING SOLID TUMOR BY TARGETING DECTIN-1 SIGNALING | Jul 30, 2017 | Abandoned |
Array
(
[id] => 13093377
[patent_doc_number] => 10066020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Methods of detecting cancer
[patent_app_type] => utility
[patent_app_number] => 15/663325
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7760
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15663325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/663325 | Methods of detecting cancer | Jul 27, 2017 | Issued |
Array
(
[id] => 12179929
[patent_doc_number] => 20180038865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'CD9 AS A THERAPEUTIC TARGET FOR HEMATOLOGIC MALIGNANCIES'
[patent_app_type] => utility
[patent_app_number] => 15/653325
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22005
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15653325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/653325 | CD9 AS A THERAPEUTIC TARGET FOR HEMATOLOGIC MALIGNANCIES | Jul 17, 2017 | Abandoned |
Array
(
[id] => 12999953
[patent_doc_number] => 10023634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Antibodies against TIM3 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/649380
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 65
[patent_no_of_words] => 78987
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649380
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/649380 | Antibodies against TIM3 and uses thereof | Jul 12, 2017 | Issued |